(−)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo

Dysregulation of epidermal growth factor receptor (EGFR)/human epidermal growth factor-2 (HER2) family is a hallmark of aggressive breast cancer. Small-molecule tyrosine kinase inhibitors are among the most effective cancer targeted treatments. (−)-Oleocanthal (OC) is a naturally occurring phenolic...

Descripción completa

Detalles Bibliográficos
Autores principales: Siddique, Abu Bakar, Ebrahim, Hassan Y., Akl, Mohamed R., Ayoub, Nehad M., Goda, Amira A., Mohyeldin, Mohamed M., Nagumalli, Suresh K., Hananeh, Wael M., Liu, Yong-Yu, Meyer, Sharon A., El Sayed, Khalid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412724/
https://www.ncbi.nlm.nih.gov/pubmed/30781364
http://dx.doi.org/10.3390/nu11020412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6412724/
https://www.ncbi.nlm.nih.gov/pubmed/30781364
http://dx.doi.org/10.3390/nu11020412

Ejemplares similares